Cargando…
Cerebral vasoconstriction reactions and plasma levels of ETBR, ET-1, and eNOS in patients with chronic high altitude disease
The aim of the present study was to examine cerebral vasoconstriction in patients with chronic high altitude disease [cerebrovascular reactivity (CVR)], and to evaluate differences in alterations of brain vascular contractile reactivity of chronic mountain sickness (CMS) patients and healthy control...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991730/ https://www.ncbi.nlm.nih.gov/pubmed/27485004 http://dx.doi.org/10.3892/mmr.2016.5555 |
_version_ | 1782448899873570816 |
---|---|
author | Wu, Shizheng Hao, Guisheng Zhang, Shukun Jiang, Dongmei Wuren, Tana Luo, Junming |
author_facet | Wu, Shizheng Hao, Guisheng Zhang, Shukun Jiang, Dongmei Wuren, Tana Luo, Junming |
author_sort | Wu, Shizheng |
collection | PubMed |
description | The aim of the present study was to examine cerebral vasoconstriction in patients with chronic high altitude disease [cerebrovascular reactivity (CVR)], and to evaluate differences in alterations of brain vascular contractile reactivity of chronic mountain sickness (CMS) patients and healthy controls. Alterations of endothelin (ET) and its receptor, as well as endothelial nitric oxide synthase (eNOS) levels in the plasma were examined to determine the cerebral reservation capacities in CMS patients. Transcranial Doppler ultrasound and carbon dioxide analysis methods were used to detect the CVR variances. At the same time, enzyme-linked immunosorbent assay approaches were utilized to detect the ET and ET B receptor and the eNOS levels in serum of the CMS patients and healthy controls. CVR and CVRI levels in CMS patients were lower than those of the healthy control subjects and the difference was statistically significant (P<0.05). By contrast, eNOS and ET-1 levels were not statistically significant for CMS and healthy controls (P>0.05). However, the ET receptor concentration level was higher in CMS than the healthy controls. Thus, ET-1 may not be a direct etiological variation but may play compensatory roles in CMS patients. The results of the study may provide scientific clues for the prevention and treatment of CMS with higher blood coagulation states of cerebral infarction in patients with chronic high altitude disease. |
format | Online Article Text |
id | pubmed-4991730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-49917302016-08-26 Cerebral vasoconstriction reactions and plasma levels of ETBR, ET-1, and eNOS in patients with chronic high altitude disease Wu, Shizheng Hao, Guisheng Zhang, Shukun Jiang, Dongmei Wuren, Tana Luo, Junming Mol Med Rep Articles The aim of the present study was to examine cerebral vasoconstriction in patients with chronic high altitude disease [cerebrovascular reactivity (CVR)], and to evaluate differences in alterations of brain vascular contractile reactivity of chronic mountain sickness (CMS) patients and healthy controls. Alterations of endothelin (ET) and its receptor, as well as endothelial nitric oxide synthase (eNOS) levels in the plasma were examined to determine the cerebral reservation capacities in CMS patients. Transcranial Doppler ultrasound and carbon dioxide analysis methods were used to detect the CVR variances. At the same time, enzyme-linked immunosorbent assay approaches were utilized to detect the ET and ET B receptor and the eNOS levels in serum of the CMS patients and healthy controls. CVR and CVRI levels in CMS patients were lower than those of the healthy control subjects and the difference was statistically significant (P<0.05). By contrast, eNOS and ET-1 levels were not statistically significant for CMS and healthy controls (P>0.05). However, the ET receptor concentration level was higher in CMS than the healthy controls. Thus, ET-1 may not be a direct etiological variation but may play compensatory roles in CMS patients. The results of the study may provide scientific clues for the prevention and treatment of CMS with higher blood coagulation states of cerebral infarction in patients with chronic high altitude disease. D.A. Spandidos 2016-09 2016-07-27 /pmc/articles/PMC4991730/ /pubmed/27485004 http://dx.doi.org/10.3892/mmr.2016.5555 Text en Copyright: © Wu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Wu, Shizheng Hao, Guisheng Zhang, Shukun Jiang, Dongmei Wuren, Tana Luo, Junming Cerebral vasoconstriction reactions and plasma levels of ETBR, ET-1, and eNOS in patients with chronic high altitude disease |
title | Cerebral vasoconstriction reactions and plasma levels of ETBR, ET-1, and eNOS in patients with chronic high altitude disease |
title_full | Cerebral vasoconstriction reactions and plasma levels of ETBR, ET-1, and eNOS in patients with chronic high altitude disease |
title_fullStr | Cerebral vasoconstriction reactions and plasma levels of ETBR, ET-1, and eNOS in patients with chronic high altitude disease |
title_full_unstemmed | Cerebral vasoconstriction reactions and plasma levels of ETBR, ET-1, and eNOS in patients with chronic high altitude disease |
title_short | Cerebral vasoconstriction reactions and plasma levels of ETBR, ET-1, and eNOS in patients with chronic high altitude disease |
title_sort | cerebral vasoconstriction reactions and plasma levels of etbr, et-1, and enos in patients with chronic high altitude disease |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991730/ https://www.ncbi.nlm.nih.gov/pubmed/27485004 http://dx.doi.org/10.3892/mmr.2016.5555 |
work_keys_str_mv | AT wushizheng cerebralvasoconstrictionreactionsandplasmalevelsofetbret1andenosinpatientswithchronichighaltitudedisease AT haoguisheng cerebralvasoconstrictionreactionsandplasmalevelsofetbret1andenosinpatientswithchronichighaltitudedisease AT zhangshukun cerebralvasoconstrictionreactionsandplasmalevelsofetbret1andenosinpatientswithchronichighaltitudedisease AT jiangdongmei cerebralvasoconstrictionreactionsandplasmalevelsofetbret1andenosinpatientswithchronichighaltitudedisease AT wurentana cerebralvasoconstrictionreactionsandplasmalevelsofetbret1andenosinpatientswithchronichighaltitudedisease AT luojunming cerebralvasoconstrictionreactionsandplasmalevelsofetbret1andenosinpatientswithchronichighaltitudedisease |